4//SEC Filing
Sorensen Mel 4
Accession 0000899243-22-008578
CIK 0001563577other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:05 PM ET
Size
5.3 KB
Accession
0000899243-22-008578
Insider Transaction Report
Form 4
Sorensen Mel
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-28+264,400→ 264,400 totalExercise: $2.24Exp: 2032-02-27→ Common Stock (264,400 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 28, 2022.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001444783
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:05 PM ET
- Size
- 5.3 KB